Advanced Search

    column
    Research Progress of Immunotherapy in Triple-Negative Breast Cancer
    ZHANG Ting-feng, YANG Ci-qiu, WANG Kun
    2021, 21(2): 65-70. DOI: 10.12019/j.issn.1671-5144.2021.02.001
    Abstract FullText HTML PDF
    IMpassion130: The Efficacy of Atezolizumab Plus Nab-Paclitaxel Treatment in Comparison With Nab-Paclitaxel Alone as First-Line Treatment of Advanced Triple-Negative Breast Cancer
    YANG Mei, SHEN Bo
    2021, 21(2): 71-75. DOI: 10.12019/j.issn.1671-5144.2021.02.002
    Abstract FullText HTML PDF
    Pambrolizumab Is Expected to Change the Choice of First-Line Treatment for Advanced Triple-Negative Breast Cancer: Review the KEYNOTE-355 Study
    ZHANG Shao-hua, ZHANG Jun-sheng
    2021, 21(2): 76-78. DOI: 10.12019/j.issn.1671-5144.2021.02.003
    Abstract FullText HTML PDF
    Re-Ignite the Hope of Neoadjuvant Immunotherapy for Early Triple-Negative Breast Cancer
    LIN Yu-xiang, SONG Chuan-gui, YUAN Jiao-mei
    2021, 21(2): 79-82. DOI: 10.12019/j.issn.1671-5144.2021.02.004
    Abstract FullText HTML PDF
    The First Prospective Randomized Controlled Phase ⅢClinical Study of Pembrolizumab Combined With Chemotherapy as Neoadjuvant Treatment for Early Triple-Negative Breast Cancer
    YANG Ci-qiu, WANG Kun, CHEN Yuan-qi
    2021, 21(2): 83-86. DOI: 10.12019/j.issn.1671-5144.2021.02.005
    Abstract FullText HTML PDF
    The Effect of Intrathecal Injection of Morphine Combined With Dexmedetomidine on the Analgesic Effect in Patients With Severe Advanced Colorectal Cancer
    HUANG Dan, NI Ming, YU Chuang-qin
    2021, 21(2): 87-92. DOI: 10.12019/j.issn.1671-5144.2021.02.006
    Abstract FullText HTML PDF
    Analysis of the Correlation Between PPARγ Promoter Methylation and Myocardial Infarction
    LUO Mei, YAN Shi-qi, CAO Gui-qiu, WANG Juan
    2021, 21(2): 93-99. DOI: 10.12019/j.issn.1671-5144.2021.02.007
    Abstract FullText HTML PDF
    Analysis of Risk Factors of Blood Transfusion During Meningioma Resection
    HUANG Yi, JIANG Xue-gao, LI Jian-hua, TANG Jie, GONG Yue-yong, ZHENG Yuan
    2021, 21(2): 100-104. DOI: 10.12019/j.issn.1671-5144.2021.02.008
    Abstract FullText HTML PDF
    Efficacy and Safety of Transbronchial Cryobiopsy in the Etiologic Diagnosis of Interstitial Lung Disease
    WANG Yu-chao, LUO Shao-hua, CHEN Ping-ping, LI Xiu-yu, XU Han-yi, CUI Jing-hua, CHEN Jing-jing, XU Xiao-yi, ZHANG Yun-hui, LI Jing
    2021, 21(2): 105-112. DOI: 10.12019/j.issn.1671-5144.2021.02.009
    Abstract FullText HTML PDF
    Molecular Features of Resistance to Crizotinib in Advanced Non-Small-Cell Lung Cancer With ALK Rearrangement
    DENG Qiu-mei, WANG Han-min, KANG Jin, YANG Jin-ji
    2021, 21(2): 113-117. DOI: 10.12019/j.issn.1671-5144.2021.02.010
    Abstract FullText HTML PDF
    The Influence of Design Type and Variable Type on the Appropriate Choice of Statistical Methods for Clinical Medical Research
    WU Jun-lin, TANG Xue-li, CHEN Xia, DAI Hao-ran, LI Jia-bin, HUANG Yan-jun, HUANG Guo-ping
    2021, 21(2): 118-123. DOI: 10.12019/j.issn.1671-5144.2021.02.011
    Abstract FullText HTML PDF
    Radical Treatments After Downstaging of Hepatocellular Carcinoma
    ZOU Wei, LV Ling, SHI Feng, CHEN Xiao-ming
    2021, 21(2): 124-128. DOI: 10.12019/j.issn.1671-5144.2021.02.012
    Abstract FullText HTML PDF